14 July 2025
Proxy advisory firm InGovern Research has raised concerns over serious lapses in Care Health Insurance, a subsidiary of Religare Enterprises. InGovern said that any governance lapses and regulatory breaches surrounding the grant of ESOPs worth over ₹400 crore to Dr Rashmi Saluja, Chairperson of Religare Enterprises and Non-Executive Director at CHIL, should be clawed back. “If IRDAI regulations were breached, shareholders deserve transparency on clawback status of ESOPs from Dr Rashmi Saluja and the clawback of fees paid to advisors,” it said. The Board should disclose all communication with IRDAI regarding the ESOP grant and the rationale for proceeding despite regulatory rejection, said the InGovern report.
Proxy advisory firm InGovern Research has raised concerns over serious lapses in Care Health Insurance, a subsidiary of Religare Enterprises. InGovern said that any governance lapses and regulatory breaches surrounding the grant of ESOPs worth over ₹400 crore to Dr Rashmi Saluja, Chairperson of Religare Enterprises and Non-Executive Director at CHIL, should be clawed back. “If IRDAI regulations were breached, shareholders deserve transparency on clawback status of ESOPs from Dr Rashmi Saluja and the clawback of fees paid to advisors,” it said. The Board should disclose all communication with IRDAI regarding the ESOP grant and the rationale for proceeding despite regulatory rejection, said the InGovern report.
Stay Connected, Stay Informed –
Don’t miss out on exclusive updates, market trends, and real-time investment opportunities. Be the first to know about the latest unlisted stocks, IPO announcements, and curated Fact Sheets, delivered straight to your WhatsApp.